Fremanezumab-Vfrm Approved by FDA for Preventative Treatment of Episodic Migraine in Children, Adolescents - Prabadin Corp

https://prabadinews.com/

Email

weborders@prabadincorp.com

Call us

+1 (786)-332-3938

Fremanezumab-Vfrm Approved by FDA for Preventative Treatment of Episodic Migraine in Children, Adolescents

Medical Supplies

August 6, 2025

By AdminPrabadin - 2 months ago

0

The FDA approved fremanezumab for pediatric migraine prevention, offering a new treatment option for children and adolescents aged 6 to 17.

administrator